HALO logo
halo search icon
Penumbra, Inc.

US$327.38

Price Change Indicator
0.83 (0.254%)
Penumbra, Inc.
PEN · NYS

Penumbra, Inc.

Start Trading PEN for Free

US$327.38

Price Arrow0.83 (0.254%)
20/05/2026 04:10:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Balance SheetNear Support
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Penumbra, Inc. Overview

PEN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Strong

About PEN

icon
icon

Telephone

1.510.748.3200

icon

Address

One Penumbra Place, Alameda, CA 94502

Description

Penumbra, Inc. is a thrombectomy company, which designs, develops, manufactures, and markets innovative medical products. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device system. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.

PEN Price Chart

Key Stats

Market Cap

US$12.84B

PE

68.80

EV/EBITDA

55.6

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 221.26 - 362.41

Trade Value (12mth)

US$45,790,005.00

1 week

1.31%

1 month

-0.14%

YTD

5.54%

1 year

20.77%

All time high

362.41

Key Fundamentals

EPS 3 yr Growth

-8730.60%

EBITDA Margin

15.00%

Operating Cashflow

$239m

Free Cash Flow Return

16.00%

ROIC

11.90%

Interest Coverage

160.40

Quick Ratio

4.30

Other Data

Shares Outstanding (Fully Diluted)

40m

HALO Sector

Healthcare

Next Company Report Date

23-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

PEN Announcements

Latest Announcements

DateAnnouncements
07 May 26
07 May 26
07 May 26
07 May 26
07 May 26

PEN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock2.370.364.57locklocklock
EPS (Fully Diluted)
 $locklocklocklock2.320.364.52locklocklock
Growth
 %locklocklocklock4,577.3-84.71,158.8locklocklock
PE
 Xlocklocklocklock108.5665.668.8locklocklock
EV/EBITDA
 Xlocklocklocklock78.579.455.6locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Penumbra, Inc. (PEN:NYS)?
Halo FAQ
The current share price of Penumbra, Inc. (PEN:NYS) is USD$327.38.
What is the 52-week high share price for Penumbra, Inc. (PEN:NYS)?
Halo FAQ
The 52-week high share price for Penumbra, Inc. (PEN:NYS) is USD$362.41.
What is the 52-week low share price for Penumbra, Inc. (PEN:NYS)?
Halo FAQ
The 52-week low share price for Penumbra, Inc. (PEN:NYS) is USD$221.26.
What is the dividend yield for Penumbra, Inc. (PEN:NYS)?
Halo FAQ
Penumbra, Inc. (PEN:NYS) does not pay a dividend.
What was Penumbra, Inc. (PEN:NYS) last dividend payment?
Halo FAQ
Penumbra, Inc. (PEN:NYS) does not pay a dividend.
What is the franking level for Penumbra, Inc. (PEN:NYS)?
Halo FAQ
Penumbra, Inc. (PEN:NYS) has a franking level of 0.00%.
In which sector is Penumbra, Inc. (PEN:NYS) classified?
Halo FAQ
Penumbra, Inc. (PEN:NYS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Penumbra, Inc. (PEN:NYS)?
Halo FAQ
The current P/E ratio for Penumbra, Inc. (PEN:NYS) is 68.80.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial